The Role of MRSA in Healthcare-Associated Pneumonia

被引:15
作者
Lam, Anna P. [1 ]
Wunderink, Richard G. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA
关键词
Staphylococcus aureus; methicillin-resistant S. aureus; vancomycin; linezolid; Panton-Valentine leukocidin (PVL); RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; VENTILATOR-ASSOCIATED PNEUMONIA; COMMUNITY-ACQUIRED PNEUMONIA; SOFT-TISSUE INFECTIONS; PLATELET MICROBICIDAL PROTEIN; CRITICALLY-ILL PATIENTS; METHICILLIN-RESISTANT; NOSOCOMIAL PNEUMONIA; DOUBLE-BLIND;
D O I
10.1055/s-0028-1119809
中图分类号
R4 [临床医学];
学科分类号
100218 [急诊医学];
摘要
An important continued trend in healthcare-associated infection, including healthcare-associated pneumonia (HCAP), is the rise of methicillin-resistant Stapbylococcus aureus (MRSA). The emergence of community-acquired strains of MRSA has complicated the management further. We review likely risk factors for MRSA HCAP, which include prior antibiotic therapy, nasal colonization, poor infection control practices, and antecedent viral infection. The multiple mechanisms of antibiotic resistance are also described, and virulence factors that may affect antibiotic choices are discussed. The limitations of vancomycin and evidence for superior outcomes with linezolid are reviewed. Alternatives for community-acquired strains and future options are mentioned.
引用
收藏
页码:52 / 60
页数:9
相关论文
共 121 条
[1]
Brief report:: Staphylococcus aureus sepsis and the waterhouse-friderichsen syndrome in children [J].
Adem, PV ;
Montgomery, CP ;
Husain, AN ;
Koogler, TK ;
Arangelovich, V ;
Humilier, M ;
Boyle-Vavra, S ;
Daum, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (12) :1245-1251
[2]
Ceftobiprole:: An extended-spectrum anti-methicillin-resistant Staphylococcus aureus cephalosporin [J].
Anderson, Shawn D. ;
Gums, John G. .
ANNALS OF PHARMACOTHERAPY, 2008, 42 (06) :806-816
[3]
[Anonymous], 2003, MORBIDITY MORTALITY, V52, P992
[4]
[Anonymous], 2003, MMWR, V52, P793
[5]
Recent advances in the treatment of infections due to resistant Staphylococcus aureus [J].
Anstead, GM ;
Owens, AD .
CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (06) :549-555
[6]
Impact of methicillin resistance on mortality in Staphylococcus aureus VAP:: a systematic review [J].
Athanassa, Z. ;
Siempos, I. I. ;
Falagas, M. E. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (03) :625-632
[7]
Dispersal of Staphylococcus aureus into the air associated with a rhinovirus infection [J].
Bassetti, S ;
Bischoff, WE ;
Walter, M ;
Bassetti-Wyss, BA ;
Mason, L ;
Reboussin, BA ;
D'Agostino, RB ;
Gwaltney, JM ;
Pfaller, MA ;
Sherertz, RJ .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (02) :196-203
[8]
Baughman Robert P, 2003, J Intensive Care Med, V18, P269, DOI 10.1177/0885066603256012
[9]
Community strains of methicillin-resistant Staphylococcus aureus as potential cause of healthcare-associated infections, Uruguay,2002-2004 [J].
Benoit, Stephen R. ;
Estivariz, Concepcion ;
Mogdasy, Cristina ;
Pedreira, Walter ;
Galiana, Antonio ;
Galiana, Alvaro ;
Bagnulo, Homero ;
Gorwitz, Rachel ;
Fosheim, Gregory E. ;
McDougal, Linda K. ;
Jernigan, Daniel .
EMERGING INFECTIOUS DISEASES, 2008, 14 (08) :1216-1223
[10]
Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression [J].
Bernardo, K ;
Pakulat, N ;
Fleer, S ;
Schnaith, A ;
Utermöhlen, O ;
Krut, O ;
Müller, S ;
Krönke, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) :546-555